OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SLSN$1.3158

Solesence Inc

Personal ProductsVerified

Solesence Inc has a market capitalization of $92.53 million and a price-to-earnings ratio of 51.69, indicating a high valuation relative to its earnings. The company's price-to-book ratio is 5.25, suggesting that the market values the company significantly above its book value. The enterprise value to EBITDA ratio is 67.75, which is notably high and may reflect investor expectations of future earnings growth or market sentiment. The company's liquidity position is characterized by a current ratio of 2.07, indicating it has sufficient current assets to cover its current liabilities. However, the operating cash flow is negative at -$8.57 million, which could signal short-term liquidity challenges. In terms of profitability, Solesence Inc has a return on equity of 10.15% and a return on assets of 3.58%, which are both below the industry median for the Personal Products sector. The company's gross profit margin is 25.88%, and its operating margin is 2.53%, both of which are lower than the industry median. These figures suggest that the company is not as efficient in converting revenue into profit as its peers. The net income margin is 0.29%, which is also below the industry median, indicating that the company is struggling to maintain profitability relative to its revenue. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if demand in its primary market declines. The absence of segment or geographic breakdowns in the financial data limits the ability to assess the company's exposure to different markets or product lines. Solesence Inc's growth trajectory is uncertain, as the available data does not provide specific revenue growth rates or future projections. The company's capital expenditure of -$2.14 million indicates a reduction in investment in long-term assets, which could signal a strategic shift or financial constraints. The free cash flow of $544,000 is positive but relatively small, which may limit the company's ability to reinvest in growth opportunities or pay dividends. The company faces several risk factors, including a medium liquidity risk due to its negative operating cash flow and a debt-to-equity ratio of 0.87. The risk assessment also notes that net cash is negative after subtracting total debt, which could lead to financial distress if not managed properly. The dilution risk is assessed as low, but the company's capital structure and potential for future dilution should be monitored closely. Recent events and disclosures do not provide specific details on recent filings or transcripts, but the company's ESG scores indicate moderate social and governance performance. The ESG controversies score of 100.00 suggests that the company has not been involved in any significant controversies, which is a positive sign for its governance and social responsibility practices.

30-day price · SLSN+0.44 (+48.6%)
Low$0.80High$1.49Close$1.35As of10 May, 00:00 UTC
Profile
CompanySolesence Inc
TickerSLSN.O
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Solesence Inc designs, develops, and sells innovative footwear solutions, primarily targeting the personal products market.

Classification. Solesence Inc is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

Solesence Inc has a market capitalization of $92.53 million and a price-to-earnings ratio of 51.69, indicating a high valuation relative to its earnings. The company's price-to-book ratio is 5.25, suggesting that the market values the company significantly above its book value. The enterprise value to EBITDA ratio is 67.75, which is notably high and may reflect investor expectations of future earnings growth or market sentiment. The company's liquidity position is characterized by a current ratio of 2.07, indicating it has sufficient current assets to cover its current liabilities. However, the operating cash flow is negative at -$8.57 million, which could signal short-term liquidity challenges. In terms of profitability, Solesence Inc has a return on equity of 10.15% and a return on assets of 3.58%, which are both below the industry median for the Personal Products sector. The company's gross profit margin is 25.88%, and its operating margin is 2.53%, both of which are lower than the industry median. These figures suggest that the company is not as efficient in converting revenue into profit as its peers. The net income margin is 0.29%, which is also below the industry median, indicating that the company is struggling to maintain profitability relative to its revenue. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if demand in its primary market declines. The absence of segment or geographic breakdowns in the financial data limits the ability to assess the company's exposure to different markets or product lines. Solesence Inc's growth trajectory is uncertain, as the available data does not provide specific revenue growth rates or future projections. The company's capital expenditure of -$2.14 million indicates a reduction in investment in long-term assets, which could signal a strategic shift or financial constraints. The free cash flow of $544,000 is positive but relatively small, which may limit the company's ability to reinvest in growth opportunities or pay dividends. The company faces several risk factors, including a medium liquidity risk due to its negative operating cash flow and a debt-to-equity ratio of 0.87. The risk assessment also notes that net cash is negative after subtracting total debt, which could lead to financial distress if not managed properly. The dilution risk is assessed as low, but the company's capital structure and potential for future dilution should be monitored closely. Recent events and disclosures do not provide specific details on recent filings or transcripts, but the company's ESG scores indicate moderate social and governance performance. The ESG controversies score of 100.00 suggests that the company has not been involved in any significant controversies, which is a positive sign for its governance and social responsibility practices.
Key takeaways
  • Solesence Inc is significantly overvalued based on its price-to-earnings and enterprise value to EBITDA ratios.
  • The company's profitability metrics, including return on equity and operating margin, are below industry medians.
  • The company's revenue is not diversified across segments or geographies, increasing its exposure to market-specific risks.
  • The company's liquidity position is weak, with a negative operating cash flow and a debt-to-equity ratio of 0.87.
  • The company's ESG scores suggest moderate social and governance performance with no significant controversies.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$62.1M
Gross profit$16.1M
Operating income$1.6M
Net income$1.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$8.6M
CapEx-$2.1M
Free cash flow$544.0k
Total assets$50.1M
Total liabilities$32.4M
Total equity$17.6M
Cash & equivalents$1.3M
Long-term debt$15.3M
Valuation
Market price$1.31
Market cap$92.5M
Enterprise value$106.5M
P/E51.7
Reported non-GAAP P/E
EV/Revenue1.7
EV/Op income67.8
EV/OCF
P/B5.2
P/Tangible book5.2
Tangible book$17.6M
Net cash-$14.0M
Current ratio2.1
Debt/Equity0.9
ROA3.6%
ROE10.2%
Cash conversion-4.8%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 185 companies
MetricSLSNActivity
Op margin2.5%6.0% medp25 0.5% · p75 12.6%below median
Net margin2.9%5.2% medp25 0.5% · p75 10.9%below median
Gross margin25.9%43.2% medp25 26.0% · p75 61.0%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.5%-3.0% medp25 -5.5% · p75 -1.3%below median
Debt / equity87.0%13.3% medp25 2.5% · p75 55.2%top quartile
Observations
IR observations
Social pillar21.02 (0-100)
Governance pillar25.68 (0-100)
ESG controversies score100.00 (0-100, higher = fewer controversies)
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 15:02 UTC#cd54f591
Market quoteclose USD 1.30 · shares 0.07B diluted
no public URL
2026-05-16 15:03 UTC#300843b7
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:38 UTCJob: bf913275